Home

Neuland Laboratories PE Ratio

Image

Neuland Laboratories Ltd

NSE: NEULANDLAB

PE

129.4

Last updated on: Aug 12, 2025

Key Highlights

  • The P/E Ratio of Neuland Laboratories Ltd is 129.4 as of 12 Aug 10:08 AM .
  • The P/E Ratio of Neuland Laboratories Ltd changed from 22.5 on March 2020 to 59.9 on March 2025 . This represents a CAGR of 17.73% over 6 years.
  • The Latest Trading Price of Neuland Laboratories Ltd is ₹ 13199 as of 12 Aug 09:59 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 39.8 in 5 years. This represents a CAGR of 13.53%.
  • The PE Ratio of Automobile industry is 21.5. The PE Ratio of Finance industry is 19.2. The PE Ratio of IT - Software industry is 26.8. The PE Ratio of Pharmaceuticals industry is 32.7. The PE Ratio of Retail industry is 102.8. The PE Ratio of Textiles industry is 53.3 in 2025.

Historical P/E Ratio of Neuland Laboratories Ltd

No data available

Company Fundamentals for Neuland Laboratories Ltd

Image

Neuland Laboratories Ltd

NSE: NEULANDLAB

Share Price

₹ 13199.95

-89.65 (-0.67%)

stock direction

Last updated on: Aug 12, 2025

Market Price of Neuland Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Neuland Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Aug 202513289.6
08 Aug 202513110
07 Aug 202512837.75
06 Aug 202512802.1
05 Aug 202512824.95
04 Aug 202513073.1
01 Aug 202513041.9
31 Jul 202513270.45
30 Jul 202513904.45
29 Jul 202513849.1

SWOT Analysis Of Neuland Laboratories Ltd

Strength

5

che

Weakness

2

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Neuland Laboratories Ltd

Asset Value vs Market Value of Neuland Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Neuland Laboratories Ltd17050
Sun Pharmaceutical Industries Ltd386917
Divis Laboratories Ltd158983
Torrent Pharmaceuticals Ltd122300
Cipla Ltd121441
Dr Reddys Laboratories Ltd101752

PE Ratio of Neuland Laboratories Ltd Explained

17050

Market cap

176

Earnings

129.4X

PE Ratio

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Neuland Laboratories Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Neuland Laboratories Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Neuland Laboratories Ltd

No data available

* All values are in %

About Neuland Laboratories Ltd

  • Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao.
  • The Company is engaged in manufacturing and selling of bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin.
  • Neuland Drugs & Pharmaceuticals Pvt.
  • Ltd., a company set up by the same promoters to manufacture bulk drugs was merged with the Company effective from April, 1992.
  • NLL manufactures bulk drugs. The Company came out with its initial public offering in Apr.'94 at a premium of Rs 35 aggregating Rs 5.69 cr, to part-finance the capacity expansion to manufacture bulk drugs and to diversify its product-mix.

Neuland Laboratories Ltd News Hub

Neuland Laboratories consolidated net profit rises 58.16% in the June 2024 quarter

Net profit of Neuland Laboratories rose 58.16% to Rs 97.87 crore in the quarter ended June 2024 as a

Read more

01 Aug 24

Neuland Laboratories to declare Quarterly Result

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 6 November 2024

Read more

18 Oct 24

Neuland Laboratories consolidated net profit declines 63.20% in the September 2024 quarter

Net profit of Neuland Laboratories declined 63.20% to Rs 32.84 crore in the quarter ended September

Read more

06 Nov 24

Neuland Laboratories Ltd leads losers in 'A' group

Hindustan Zinc Ltd, Five-Star Business Finance Ltd, Great Eastern Shipping Company Ltd and Triveni E

Read more

06 Nov 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Neuland Laboratories Ltd

What is the current PE Ratio of Neuland Laboratories Ltd?

The Current PE Ratio of Neuland Laboratories Ltd is 129.38 as on 12 Aug 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 32.7 as on 12 Aug 2025.

What was the PE Ratio of Neuland Laboratories Ltd last year?

The PE Ratio of Neuland Laboratories Ltd was 27.0 last year, now the PE ratio is 129.38, showing a year-on-year growth of 379.2%.

What does the PE Ratio of Neuland Laboratories Ltd indicate about its stock?

The PE Ratio of Neuland Laboratories Ltd is 129.38. This ratio indicates that investors are willing to pay 129.38 times the earnings per share for each share of Neuland Laboratories Ltd.

What is the PE Ratio Growth of Neuland Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Neuland Laboratories Ltd grew by 379.2% whereas, the EPS ratio grew by -50.0.

How does the PE ratio of Neuland Laboratories Ltd compare to industry peers?

The PE ratio of Neuland Laboratories Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Neuland Laboratories Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Neuland Laboratories Ltd PE Ratio.

What factors influence the PE ratio of Neuland Laboratories Ltd PE Ratio?

The PE ratio of Neuland Laboratories Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Neuland Laboratories Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Neuland Laboratories Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Neuland Laboratories Ltd PE Ratio?

You can check the latest PE ratio of Neuland Laboratories Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Neuland Laboratories Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Neuland Laboratories Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Neuland Laboratories Ltd PE Ratio predict future stock performance?

While the Neuland Laboratories Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions